Ambience Healthcare on Tuesday announced $243 million in new funding, bringing its valuation to $1.25 billion.

Apellis Pharmaceuticals won approval from the FDA to expand the use of its drug Empaveli to include treatment for patients ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, ...